Kintor Pharmaceutical Limited (HKG:9939)
Hong Kong
· Delayed Price · Currency is HKD 1.220
-0.020 (-1.61%)
May 16, 2025, 4:08 PM HKT
Kintor Pharmaceutical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -155.29 | -1,061 | -954.37 | -842.1 | -508.3 | Upgrade
|
| Depreciation & Amortization | 17.49 | 18.86 | 18.24 | 10.37 | 6.34 | Upgrade
|
| Other Amortization | 0.13 | 0.12 | 0.15 | 0.14 | 0.17 | Upgrade
|
| Loss (Gain) From Sale of Assets | -2.52 | -0.01 | 0.62 | 0.11 | -0.64 | Upgrade
|
| Asset Writedown & Restructuring Costs | 13.82 | 134.07 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -0 | -0.49 | -2 | -0.78 | -2.13 | Upgrade
|
| Loss (Gain) on Equity Investments | 1.43 | -0.05 | 0.57 | - | - | Upgrade
|
| Stock-Based Compensation | -9.11 | 22.99 | 95.64 | 37.35 | 28.16 | Upgrade
|
| Provision & Write-off of Bad Debts | 1.21 | - | - | - | - | Upgrade
|
| Other Operating Activities | -15.1 | 594.24 | 77.85 | 28.13 | 108.41 | Upgrade
|
| Change in Accounts Receivable | 8.57 | 7.62 | 94.23 | -86.03 | -13.02 | Upgrade
|
| Change in Inventory | -4.32 | -0.38 | -345.13 | -351.36 | - | Upgrade
|
| Change in Accounts Payable | -49.95 | -106.84 | 6.76 | 155.32 | 7.6 | Upgrade
|
| Change in Unearned Revenue | - | -0.3 | 15.94 | 3.65 | -0.44 | Upgrade
|
| Change in Other Net Operating Assets | -5.44 | 3.41 | 30.24 | -6.16 | -7.02 | Upgrade
|
| Operating Cash Flow | -199.08 | -387.58 | -961.26 | -1,051 | -380.88 | Upgrade
|
| Capital Expenditures | -1.54 | -2.72 | -27.47 | -76.24 | -69.03 | Upgrade
|
| Sale of Property, Plant & Equipment | 10.66 | 0.21 | 0.2 | 0.01 | 0.75 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.14 | - | -0.18 | -29.5 | -27.13 | Upgrade
|
| Investment in Securities | 10 | -0.85 | 97.84 | 195.53 | -345.18 | Upgrade
|
| Other Investing Activities | 1.05 | 6.64 | -3.19 | 2.2 | 0.86 | Upgrade
|
| Investing Cash Flow | 20.03 | 3.27 | 67.2 | 92.01 | -439.73 | Upgrade
|
| Long-Term Debt Issued | 34.28 | 70 | 170 | 20 | 239 | Upgrade
|
| Long-Term Debt Repaid | -154.33 | -104.22 | -53.01 | -112.52 | -82.3 | Upgrade
|
| Net Debt Issued (Repaid) | -120.04 | -34.22 | 116.99 | -92.52 | 156.7 | Upgrade
|
| Issuance of Common Stock | 0.37 | 0.76 | 698.76 | 951.97 | 1,653 | Upgrade
|
| Other Financing Activities | - | - | - | -2.03 | -29.14 | Upgrade
|
| Financing Cash Flow | -119.67 | -33.46 | 815.75 | 857.42 | 1,780 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2.11 | -2.67 | 16.45 | -36.42 | -90.53 | Upgrade
|
| Net Cash Flow | -296.61 | -420.44 | -61.86 | -138.36 | 869.16 | Upgrade
|
| Free Cash Flow | -200.62 | -390.3 | -988.73 | -1,128 | -449.92 | Upgrade
|
| Free Cash Flow Margin | -4012.36% | - | - | -3294.09% | - | Upgrade
|
| Free Cash Flow Per Share | -0.47 | -0.91 | -2.63 | -3.16 | -1.45 | Upgrade
|
| Cash Interest Paid | 9.29 | 12.12 | 9.96 | 6.77 | 7.65 | Upgrade
|
| Cash Income Tax Paid | 0.02 | 0.29 | 0.91 | 0.81 | 0.07 | Upgrade
|
| Levered Free Cash Flow | -155.8 | -119.81 | -681.67 | -895.55 | -314.92 | Upgrade
|
| Unlevered Free Cash Flow | -150 | -113.75 | -676.55 | -893.99 | -312.81 | Upgrade
|
| Change in Net Working Capital | 61.37 | -508.12 | 157.23 | 314.42 | 1.47 | Upgrade
|
Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.